Inhibition of Pathogenic Mutant SOD1 Aggregation in Cultured Motor Neuronal Cells by Prevention of Its SUMOylation on Lysine 75

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the selective death of motor neurons. Mutations in the SOD1 gene encoding the superoxide dismutase 1 are present in 15% of familial ALS cases and in 2% of sporadic cases. These mutations are associated with the formation of SOD1-positive aggregates. The mechanisms of aggregation remain unknown, but posttranslational modifications of SOD1 may be involved. Here, we report that NSC-34 motor neuronal cells expressing mutant SOD1 contained aggregates positive for small ubiquitin modifier-1 (SUMO-1), and in parallel a reduced level of free SUMO-1. CLEM (correlative light and electron microscopy) analysis showed nonorganized cytosolic aggregates for all mutations tested (SOD1A4V, SOD1V31A, and SOD1G93C). We next show that preventing the SUMOylation of mutant SOD1 by the substitution of lysine 75, the SUMOylation site of SOD1, significantly reduces the number of motor neuronal cells with aggregates. These results support the need for further research on the SUMOylation pathways, which may be a potential therapeutic target in ALS.

[1]  T. Niikura,et al.  SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants , 2014, PloS one.

[2]  J. Pouget,et al.  A novel SOD1 mutation p.V31A identified with a slowly progressive form of amyotrophic lateral sclerosis , 2014, Neurobiology of Aging.

[3]  B. Kalmar,et al.  Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis , 2013, PloS one.

[4]  Jaclyn R. Gareau,et al.  SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation , 2013, Cell reports.

[5]  Jochen H Weishaupt,et al.  Sumoylation in neurodegenerative diseases , 2013, Cellular and Molecular Life Sciences.

[6]  J. Henley,et al.  SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons , 2013, PloS one.

[7]  P. Vourc'h,et al.  Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis , 2013, The International journal of neuroscience.

[8]  Ammar Al-Chalabi,et al.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.

[9]  J. Lachuer,et al.  Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis‐linked mutant SOD1 cultured neurons , 2011, Journal of neuroscience research.

[10]  K. Chung,et al.  Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation , 2011, Journal of the Neurological Sciences.

[11]  Jaclyn R. Gareau,et al.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition , 2010, Nature Reviews Molecular Cell Biology.

[12]  A. Levey,et al.  Multiplex SILAC Analysis of a Cellular TDP-43 Proteinopathy Model Reveals Protein Inclusions Associated with SUMOylation and Diverse Polyubiquitin Chains* , 2010, Molecular & Cellular Proteomics.

[13]  J. Iñiguez-Lluhí,et al.  Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation*♦ , 2009, The Journal of Biological Chemistry.

[14]  S. Jentsch,et al.  Principles of ubiquitin and SUMO modifications in DNA repair , 2009, Nature.

[15]  P. Riso,et al.  Mutation of SOD1 in ALS: a gain of a loss of function. , 2007, Human molecular genetics.

[16]  P. Fraser,et al.  SUMO on the road to neurodegeneration. , 2007, Biochimica et biophysica acta.

[17]  V. Kirkin,et al.  Role of ubiquitin- and Ubl-binding proteins in cell signaling. , 2007, Current opinion in cell biology.

[18]  X. Yao,et al.  SUMO-1 modification increases human SOD1 stability and aggregation , 2006, Neuroscience Research.

[19]  Fujian Zhang,et al.  Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. , 2006, Biochimica et biophysica acta.

[20]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[21]  P. Andersen,et al.  Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes , 2006, Neuroscience Letters.

[22]  M. Baptista,et al.  Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. , 2005, Brain : a journal of neurology.

[23]  J. Rothstein,et al.  Aggregate Formation in Cu,Zn Superoxide Dismutase-related Proteins* , 2003, The Journal of Biological Chemistry.

[24]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[25]  Robert H. Brown,et al.  Familial Amyotrophic Lateral Sclerosis-associated Mutations Decrease the Thermal Stability of Distinctly Metallated Species of Human Copper/Zinc Superoxide Dismutase* , 2002, The Journal of Biological Chemistry.

[26]  D. Price,et al.  Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.

[27]  L. Bruijn,et al.  Toxicity of ALS-linked SOD1 mutants. , 2000, Science.

[28]  A. Wernimont,et al.  Crystal structure of the copper chaperone for superoxide dismutase , 1999, Nature Structural Biology.

[29]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[30]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[31]  M. Pericak-Vance,et al.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.

[32]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[33]  M. Gurney,et al.  Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. , 1996, Pathologie-biologie.